Novanta (NASDAQ:NOVT – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.630-0.710 for the period, compared to the consensus earnings per share estimate of 0.780. The company issued revenue guidance of $232.0 million-$236.0 million, compared to the consensus revenue estimate of $244.9 million. Novanta also updated its FY 2025 guidance to 3.350-3.550 EPS.
Novanta Trading Down 1.6 %
NOVT opened at $138.30 on Tuesday. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.79 and a quick ratio of 1.81. The company has a market cap of $4.97 billion, a price-to-earnings ratio of 82.81 and a beta of 1.28. The firm has a 50 day simple moving average of $149.48 and a 200 day simple moving average of $164.96. Novanta has a fifty-two week low of $138.15 and a fifty-two week high of $187.12.
Novanta (NASDAQ:NOVT – Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The technology company reported $0.76 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.05). Novanta had a return on equity of 15.20% and a net margin of 6.52%. On average, sell-side analysts anticipate that Novanta will post 3.03 earnings per share for the current year.
Analysts Set New Price Targets
View Our Latest Analysis on Novanta
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Further Reading
- Five stocks we like better than Novanta
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- The Behemoth BlackRock’s Next Trillion Comes From Private Assets
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Rivian’s Rough Patch: Is the Dip a Doorway to Long-Term Gains?
- How to Effectively Use the MarketBeat Ratings Screener
- Institutions Signal Opportunty to Buy High-Yield Kraft-Heinz
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.